Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in France / NCT07271277
Starting soon Not applicable

3D MRI Assessment of Femoroacetabular Impingement in Patients With ACL Rupture - Exploratory Study

NCT07271277 · tracked via the Priya Life Science France tracker
Sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche
Phase
Not applicable
Started
2026-10-01
Last updated
2026-08-20

Condition(s) studied

Femoroacetabular Impingement

Investigational drug(s) / intervention(s)

3D MRI

3D MRI: Intervention consists of performing a 3D MRI scan of both hips using a T1 sequence.

Study summary

Anterior cruciate ligament (ACL) tears are among the most common sports injuries. Numerous studies have shown that reduced hip rotation may play a role in ACL tears. The same question may also arise for hip injuries such as femoroacetabular impingement (FAI).

This research is based on the hypothesis that there is a relationship between FAI and ACL injury. In this context, 3D MRI of the hip would provide morphological details of the hip that are not currently available with other imaging techniques, thereby enabling early identification of FAI. This is the reason why this research has been initiated.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patient, male or female, aged 18 years or older * Patient with a primary complete ACL rupture * Patient affiliated with or covered by a social security scheme * Patient who speaks French and has signed an informed consent form Exclusion Criteria: * Patient with multi-ligament injury * Patients with a history of hip fracture * Patients with a history of hip surgery * Patients with a contraindication to MRI * Protected individuals: adults under guardianship, curatorship or other legal protection, deprived of their liberty by judicial or administrative decision * Pregnant or breastfeeding women

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Hôpital Privé Jean Mermoz Lyon France

More GCS Ramsay Santé pour l'Enseignement et la Recherche trials in France

Incidence of Diaphragmatic Dysfunction After Non-Intubated Video-Assisted Thoracoscopic Surgery Recruiting
Outpatient Laparoscopic Radical Prostatectomy Recruiting
Early Maladaptive Schemas in French Health Care Professionals With Burn Out Recruiting
Anterior Cruciate Ligament Reconstruction Recruiting
Respiratory Variability in Patients With Acute Hypoxemic Respiratory Failure and Placed on High Flow Oxygen Therapy Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07271277 on ClinicalTrials.gov ↗ ← All trials in France